History & Overview Annual Report President's Pages Center News Community Affairs Code of Conduct
Make a Gift Cycle for Survival Fred's Team Yankees Universe Fund Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck CELEBRATIONS
Press Releases In the News Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days IS Careers Job Search & Apply Online
Making an Appointment

Assessing the Value of PSA Screening for Prostate Cancer

PSA Screening
For years, men have been told that the best way to deal with the threat of prostate cancer is to get regular prostate specific antigen (PSA) tests. Two recent studies evaluated the usefulness of this screening approach. One of the studies showed a significant, albeit modest, reduction in death from prostate cancer for previously unscreened men. The other study, which included half as many men, showed no reduction in cancer mortality for men receiving PSA testing. In addition to raising questions about the usefulness of PSA screening, these interim studies also suggest that there is a high risk of overdiagnosis and, consequently, overtreatment associated with the currently issued guidelines.

What's New at MSKCC.ORG

Updated Soft Tissue Sarcoma Section

Memorial Sloan-Kettering Cancer Center's Soft Tissue Sarcoma Disease Management Team -- including specialists in epidemiology, surgery, medical oncology, radiation oncology, diagnostic radiology, pathology, biostatistics, immunology, and psychiatry -- has treated more than 8,000 soft tissue sarcoma patients.

Updated Metastatic Brain Tumors Section

If you or your loved one has been diagnosed with a tumor in the brain that has spread from elsewhere in the body (known as a metastatic brain tumor), Memorial Sloan-Kettering Cancer Center is ready to help. Our experienced team of doctors, nurses, and other healthcare professionals is dedicated to providing the highest-quality treatment, counseling, and palliative care for patients with this disease.

Updated Prostate Cancer Prediction Tool

Our prostate cancer prediction tool, called a nomogram, is designed to help physicians and patients decide which treatment approaches will result in the greatest benefit. It is recommended that patients using the tool consult with a physician or other professional healthcare provider prior to making any treatment decisions.

2008 Annual Report Online

Our 2008 Annual Report features the leading-edge work being done every day at Memorial Sloan-Kettering -- work that is making the difference in the lives of patients today and those we will see in the future.

Research at Memorial Sloan-Kettering

Genes Found to Play a Role in Breast Cancer's Spread to the Brain

New research led by investigators at Memorial Sloan-Kettering Cancer Center identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the mechanisms by which this spread occurs.

Genetic Abnormality May Increase Risk of Blood Disorders

Researchers at Memorial Sloan-Kettering Cancer Center have shown for the first time that a tendency to develop some blood disorders may be inherited.

Investigators Harness microRNAs for Therapeutic Cell Engineering

Memorial Sloan-Kettering Cancer Center investigators have found a new technique to control gene expression in mice.

Staff Spotlight

An Interview with Ross Levine

Ross L. Levine is an assistant member in the Human Oncology and Pathogenesis Program and holder of a Geoffrey Beene Junior Faculty Chair. He analyzes the genetic makeup of cancer cells to identify disease pathways.

Video Webcasts

Breast Cancer Medicine, Present and Future Webcast

Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs, provides an overview of the latest advances in the prevention and treatment of breast cancer.

Major Trends in Modern Cancer Research Webcast

Leading Memorial Sloan-Kettering researchers -- Harold Varmus, Kathryn Anderson, Prasad Jallepalli, and Kenneth Offit -- highlight current trends in cancer research, explaining cancer mutations, cell division, and clinical genetics.

Survivorship Events

Rock & Run on the River

The countdown has begun for Rock & Run on the River, which takes place on Sunday, June 7. Register today to run, walk, or volunteer, and join us at this 5K run/walk and celebration, featuring live entertainment, delicious food, and fun for the whole family, proceeds from which support Memorial Sloan-Kettering's Cancer Survivorship Initiative. Online registration for the event closes on Friday, June 5. If you miss the online deadline, you can register on the day of the event from 6:30-8:00 AM.

Survivorship Resources

New Issue of Bridges, Memorial Sloan-Kettering's Survivorship Newsletter

The summer issue of Bridges, Memorial Sloan-Kettering's newsletter for survivors written by survivors, is now available online. Bridges offers a forum where patients and their families can share stories of inspiration and hope, as well as the challenges that accompany the cancer survivor's journey.
Last Updated: May. 27, 2009
Bookmark and SharePrintEmail This Page